However, patients with COVID-19 and aTB exhibited a reduced immune response, characterized by lower IFN-γ response to SARS-CoV-2 specific antigens and lower functional response of lymphocytes that will lead to higher morbidity and mortality. Here, IFNG is linked to COVID-19.